The green tea polyphenol ()-epigallocatechin-3-gallate ameliorates experimental immune-mediated glomerulonephritis

Kidney International

Volumn 80, Issue 6, 2011, Pages 601-611

  Peng, Ai ^a,b   Ye, Ting ^b,c   Rakheja, Dinesh ^b   Tu, Yangke ^b,d   Wang, Tao ^b   Du, Yong ^b   Zhou, Jason K ^b   Vaziri, Nosratola D ^e   Hu, Zhao ^f   Mohan, Chandra ^b   Zhou, Xin J ^b  

^a TONGJI UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d TIANJIN FIRST CENTRAL HOSPITAL   (China)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f SHANDONG UNIVERSITY   (China)

Author keywords

anti GBM disease; nitric oxide; oxidative stress; reactive oxygen species; renal pathology

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; 3 NITROTYROSINE; COPPER ZINC SUPEROXIDE DISMUTASE; CREATININE; EPIGALLOCATECHIN GALLATE; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; MALONALDEHYDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYELOPEROXIDASE; NITRIC OXIDE; OSTEOPONTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; POLYPHENOL; PROTEIN KINASE B; PROTEIN P47; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TRANSCRIPTION FACTOR RELA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG TARGETING; GLOMERULONEPHRITIS; HISTOPATHOLOGY; MALE; MORTALITY; MOUSE; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEINURIA; RENAL PROTECTION; TEA;

EID: 80052269190     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.121     Document Type: Article

References (48)

1. Pedchenko V, Bondar O, Fogo AB et al. Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis. N Engl J Med 2010; 363: 343-354.
2. Borza DB, Neilson EG, Hudson BG. Pathogenesis of Goodpasture syndrome: a molecular perspective. Semin Nephrol 2003; 23: 522-531. (Pubitemid 38030086)
3. Kalluri R, Wilson CB, Weber M et al. Identification of the alpha 3 chain of type IV collagen as the common autoantigen in antibasement membrane disease and Goodpasture syndrome. J Am Soc Nephrol 1995; 6: 1178-1185.
4. Rogers TE, Rakheja D, Zhou XJ. Glomerular diseases associated with nephritic syndrome and/or rapidly progressive glomerulonephritis. In: Zhou XJ, Laszik Z, Nadasdy T, et al. (eds). Silva's Diagnostic Renal Pathology. Cambridge University Press: New York, 2009, pp 178-228.
5. Little MA, Pusey CD. Rapidly progressive glomerulonephritis: current and evolving treatment strategies. J Nephrol 2004; 17(Suppl 8): S10-S19. (Pubitemid 44178734)
6. Valko M, Leibfritz D, Moncol J et al. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007; 39: 44-84. (Pubitemid 44566469)
7. Rehan A, Johnson KJ, Wiggins RC et al. Evidence for the role of oxygen radicals in acute nephrotoxic nephritis. Lab Invest 1984; 51: 396-403. (Pubitemid 14021012)
8. Shah SV, Baliga R, Rajapurkar M et al. Oxidants in chronic kidney disease. J Am Soc Nephrol 2007; 18: 16-28. (Pubitemid 46053418)
9. Duann P, Datta PK, Pan C et al. Superoxide dismutase mimetic preserves the glomerular capillary permeability barrier to protein. J Pharmacol Exp Ther 2006; 316: 1249-1254. (Pubitemid 43345300)
10. Takano K, Nakaima K, Nitta M et al. Inhibitory effect of (2)-epigallocatechin 3-gallate, a polyphenol of green tea, on neutrophil chemotaxis in vitro and in vivo. J Agric Food Chem 2004; 52: 4571-4576.
11. Tipoe GL, Leung TM, Hung MW et al. Green tea polyphenols as an anti-oxidant and anti-inflammatory agent for cardiovascular protection. Cardiovasc Hematol Disord Drug Targets 2007; 7: 135-144. (Pubitemid 47024129)
12. Katiyar SK, Matsui MS, Elmets CA et al. Polyphenolic antioxidant (2)-epigallocatechin-3-gallate from green tea reduces UVB-induced inflammatory responses and infiltration of leukocytes in human skin. Photochem Photobiol 1999; 69: 148-153. (Pubitemid 129606899)
13. Lambert JD, Elias RJ. The antioxidant and pro-oxidant activities of green tea polyphenols: a role in cancer prevention. Arch Biochem Biophys 2010; 501: 65-72.
14. Clark J, You M. Chemoprevention of lung cancer by tea. Mol Nutr Food Res 2006; 50: 144-151. (Pubitemid 43325655)
15. Nishikawa H, Wakano K, Kitani S. Inhibition of NADPH oxidase subunits translocation by tea catechin EGCG in mast cell. Biochem Biophys Res Commun 2007; 362: 504-509. (Pubitemid 47332438)
16. Morre DJ, Bridge A, Wu LY et al. Preferential inhibition by (2)-epigallocatechin-3-gallate of the cell surface NADH oxidase and growth of transformed cells in culture. Biochem Pharmacol 2000; 60: 937-946.
17. Li W, Nie S, Xie M et al. A major green tea component, (2)-epigallocatechin-3-gallate, ameliorates doxorubicin-mediated cardiotoxicity in cardiomyocytes of neonatal rats. J Agric Food Chem: e-pub ahead of print 28 July 2010.
18. Sahin K, Tuzcu M, Gencoglu H et al. Epigallocatechin-3-gallate activates Nrf2/HO-1 signaling pathway in cisplatin-induced nephrotoxicity in rats. Life Sci 2010; 87: 240-245.
19. Turko IV, Marcondes S, Murad F. Diabetes-associated nitration of tyrosine and inactivation of succinyl-CoA:3-oxoacid CoA-transferase. Am J Physiol Heart Circ Physiol 2001; 281: H2289-H2294.
20. Fortin CF, McDonald PP, Fulop T et al. Sepsis, leukocytes, and nitric oxide (NO): an intricate affair. Shock 2010; 33: 344-352.
21. Nakagawa T, Yokozawa T. Direct scavenging of nitric oxide and superoxide by green tea. Food Chem Toxicol 2002; 40: 1745-1750. (Pubitemid 35284144)
22. Tomita N, Morishita R, Lan HY et al. In vivo administration of a nuclear transcription factor-kappaB decoy suppresses experimental crescentic glomerulonephritis. J Am Soc Nephrol 2000; 11: 1244-1252. (Pubitemid 30416220)
23. Ruiz-Ortega M, Bustos C, Hernandez-Presa MA et al. Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis. J Immunol 1998; 161: 430-439. (Pubitemid 28285552)
24. Panzer U, Steinmetz OM, Turner JE et al. Resolution of renal inflammation: a new role for NF-kappaB1 (p50) in inflammatory kidney diseases. Am J Physiol Renal Physiol 2009; 297: F429-F439.
25. Yamabe N, Yokozawa T, Oya T et al. Therapeutic potential of (2)-epigallocatechin 3-O-gallate on renal damage in diabetic nephropathy model rats. J Pharmacol Exp Ther 2006; 319: 228-236. (Pubitemid 44455127)
26. Khan N, Afaq F, Saleem M et al. Targeting multiple signaling pathways by green tea polyphenol (2)-epigallocatechin-3-gallate. Cancer Res 2006; 66: 2500-2505.
27. Beltz LA, Bayer DK, Moss AL et al. Mechanisms of cancer prevention by green and black tea polyphenols. Anticancer Agents Med Chem 2006; 6: 389-406. (Pubitemid 44377775)
28. Hudkins KL, Giachelli CM, Eitner F et al. Osteopontin expression in human crescentic glomerulonephritis. Kidney Int 2000; 57: 105-116. (Pubitemid 30227758)
29. Yu XQ, Fan JM, Nikolic-Paterson DJ et al. IL-1 up-regulates osteopontin expression in experimental crescentic glomerulonephritis in the rat. Am J Pathol 1999; 154: 833-841. (Pubitemid 29122602)
30. Yu XQ, Nikolic-Paterson DJ, Mu W et al. A functional role for osteopontin in experimental crescentic glomerulonephritis in the rat. Proc Assoc Am Physicians 1998; 110: 50-64. (Pubitemid 28051638)
31. Lan HY, Yu XQ, Yang N et al. De novo glomerular osteopontin expression in rat crescentic glomerulonephritis. Kidney Int 1998; 53: 136-145. (Pubitemid 28066913)
32. Sarafidis PA, Bakris GL. Protection of the kidney by thiazolidinediones: an assessment from bench to bedside. Kidney Int 2006; 70: 1223-1233. (Pubitemid 44435173)
33. Haraguchi K, Shimura H, Onaya T. Suppression of experimental crescentic glomerulonephritis by peroxisome proliferator-activated receptor (PPAR)gamma activators. Clin Exp Nephrol 2003; 7: 27-32. (Pubitemid 36460538)
34. Ko GJ, Kang YS, Han SY et al. Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats. Nephrol Dial Transplant 2008; 23: 2750-2760.
35. Ma LJ, Marcantoni C, Linton MF et al. Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats. Kidney Int 2001; 59: 1899-1910. (Pubitemid 32336806)
36. Miyazaki Y, Cersosimo E, Triplitt C et al. Rosiglitazone decreases albuminuria in type 2 diabetic patients. Kidney Int 2007; 72: 1367-1373. (Pubitemid 350126770)
37. Kincaid-Smith P, Fairley KF, Farish S et al. Reduction of proteinuria by rosiglitazone in non-diabetic renal disease. Nephrology (Carlton) 2008; 13: 58-62.
38. Aprahamian T, Bonegio RG, Richez C et al. The peroxisome proliferatoractivated receptor gamma agonist rosiglitazone ameliorates murine lupus by induction of adiponectin. J Immunol 2009; 182: 340-346.
39. Afaq F, Adhami VM, Ahmad N et al. Inhibition of ultraviolet B-mediated activation of nuclear factor kappaB in normal human epidermal keratinocytes by green tea Constituent (2)-epigallocatechin-3-gallate. Oncogene 2003; 22: 1035-1044. (Pubitemid 36313147)
40. Peairs A, Dai R, Gan L et al. Epigallocatechin-3-gallate (EGCG) attenuates inflammation in MRL/lpr mouse mesangial cells. Cell Mol Immunol 2010; 7: 123-132.
41. Lu H, Zhen J, Wu T et al. Superoxide dismutase mimetic drug tempol aggravates anti-GBM antibody induced glomerulonephritis in mice. Am J Physiol Renal Physiol 2010; 299: F445-F452.
42. Xie C, Sharma R, Wang H et al. Strain distribution pattern of susceptibility to immune-mediated nephritis. J Immunol 2004; 172: 5047-5055. (Pubitemid 38456432)
43. Wu T, Xie C, Bhaskarabhatla M et al. Excreted urinary mediators in an animal model of experimental immune nephritis with potential pathogenic significance. Arthritis Rheum 2007; 56: 949-959. (Pubitemid 46399442)
44. Xie C, Qin X, Jonnala G et al. Enhanced susceptibility to immune nephritis in DBA/1 mice is contingent upon IL-1 expression. Clin Immunol 2007; 124: 49-56. (Pubitemid 46951035)
45. Goodin MG, Fertuck KC, Zacharewski TR et al. Estrogen receptormediated actions of polyphenolic catechins in vivo and in vitro. Toxicol Sci 2002; 69: 354-361. (Pubitemid 35244210)
46. Zinellu A, Caria MA, Tavera C et al. Plasma creatinine and creatine quantification by capillary electrophoresis diode array detector. Anal Biochem 2005; 342: 186-193. (Pubitemid 40884565)
47. Zhou XJ, Laszik Z, Wang XQ et al. Association of renal injury with increased oxygen free radical activity and altered nitric oxide metabolism in chronic experimental hemosiderosis. Lab Invest 2000; 80: 1905-1914. (Pubitemid 32012758)
48. Zhen J, Lu H, Wang XQ et al. Upregulation of endothelial and inducible nitric oxide synthase expression by reactive oxygen species. Am J Hypertens 2008; 21: 28-34.